A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

Summary

The purpose of this study is to investigate the antiviral activity of JNJ-64281802 versus placebo in terms of reduction of dengue virus (DENV) ribonucleic acid (RNA) in primary DENV infection.

Timeline

Start

2022-01-24

Primary completion

2022-09-24

Completion

2023-03-21

Outcome

Outcome not reported

Stopped (Enrollment): “Feasibility of enrollment impacted by COVID”

Drugs

Indications